This resulted in the up-regulation of EZH2-silenced tumor suppressor genes, including CDKN1C, DAB2IP, and WNT5a, in a dose-dependent manner in multiple cancer cell lines (e.g., T24, MBT2, and PC3) (Figs. 4B-4D). The gene discussed is DAB2IP; the disease is cancer.